Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 6, p. 185, doi. 10.1177/2040620717703012
- By:
- Publication type:
- Article